Page last updated: 2024-08-17

quinoxalines and Spinal Cord Diseases

quinoxalines has been researched along with Spinal Cord Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ankeny, DP; Banerjee, R; Garg, SK; Guan, Z; Kigerl, KA; Lai, W; McTigue, DM; Popovich, PG; Wei, P1
Bell, G; Farag, E; Kalfas, I; Kovaci, B; Kurz, A; Mascha, EJ; Rockwood, E; Sessler, DI; Wang, L1

Trials

1 trial(s) available for quinoxalines and Spinal Cord Diseases

ArticleYear
Effects of crystalloid versus colloid and the α-2 agonist brimonidine versus placebo on intraocular pressure during prone spine surgery: a factorial randomized trial.
    Anesthesiology, 2012, Volume: 116, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Chemistry, Pharmaceutical; Colloids; Crystalloid Solutions; Female; Humans; Intraocular Pressure; Intraoperative Care; Isotonic Solutions; Male; Middle Aged; Prone Position; Quinoxalines; Spinal Cord Diseases; Treatment Outcome

2012

Other Studies

1 other study(ies) available for quinoxalines and Spinal Cord Diseases

ArticleYear
System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo.
    Experimental neurology, 2012, Volume: 233, Issue:1

    Topics: Animals; Cystine; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Gene Expression Regulation; Glutamic Acid; Glutathione; Laser Capture Microdissection; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Nerve Tissue Proteins; Neurons; Oxidation-Reduction; Quinoxalines; Spinal Cord Diseases

2012